Therapeutic Goods (Prescription Medicines—Information Accompanying Applications for Registration) Determination 2021
6Form of information
Start here
Get a plain-English read of 6
Turn the raw legal text into a practical explanation grounded in Therapeutic Goods (Prescription Medicines—Information Accompanying Applications for Registration) Determination 2021.
6 Form of information
For the purposes of subparagraph 23B(2)(d)(ii) of the Act, the information in an application dossier, that accompanies an application for the registration of a medicine mentioned in Schedule 1, must be in: (a) the eCTD format; or (b) if exceptional circumstances exist—another format with the prior written agreement of the Therapeutic Goods Administration.